Marco F. Schmidt

784 total citations
21 papers, 609 citations indexed

About

Marco F. Schmidt is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Marco F. Schmidt has authored 21 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Computational Theory and Mathematics. Recurrent topics in Marco F. Schmidt's work include Chemical Synthesis and Analysis (5 papers), Computational Drug Discovery Methods (5 papers) and Click Chemistry and Applications (4 papers). Marco F. Schmidt is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Computational Drug Discovery Methods (5 papers) and Click Chemistry and Applications (4 papers). Marco F. Schmidt collaborates with scholars based in Germany, United Kingdom and Jordan. Marco F. Schmidt's co-authors include Jörg Rademann, Rolf Hilgenfeld, Samer Al‐Gharabli, Sandro Keller, Li Zhu, Evgeni Ponimaskin, Albert Isidro‐Llobet, Jinzhi Tan, Michael Lisurek and Shashidhar N. Rao and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Trends in biotechnology.

In The Last Decade

Marco F. Schmidt

21 papers receiving 603 citations

Peers

Countries citing papers authored by Marco F. Schmidt

Since Specialization

Citations

This map shows the geographic impact of Marco F. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco F. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco F. Schmidt more than expected).

Fields of papers citing papers by Marco F. Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco F. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco F. Schmidt. The network helps show where Marco F. Schmidt may publish in the future.

Co-authorship network of co-authors of Marco F. Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Marco F. Schmidt. A scholar is included among the top collaborators of Marco F. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco F. Schmidt. Marco F. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records 2025 ·Neuropsychopharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matthew O. Parker, (unknown), Charles N. J. Ravarani, Marco F. Schmidt, Karl Æ. Karlsson	3
2	Exploring disease-causing traits for drug repurposing in critically ill COVID-19 patients: A causal inference approach 2023 ·iScience ·(unknown), (unknown), Colin Bannard, (unknown), (unknown), Sarah Groves, Charles N. J. Ravarani, Borko Amulic, (unknown), Marco F. Schmidt	1
3	Interaction-Based Feature Selection Algorithm Outperforms Polygenic Risk Score in Predicting Parkinson’s Disease Status 2021 ·Frontiers in Genetics ·(unknown), (unknown), (unknown), Charles N. J. Ravarani, Erwin P. Böttinger, Stefan Konigorski, Marco F. Schmidt	6
4	Single-molecule chemistry. Part I: monitoring oxidation of G in oligonucleotides using CY3 fluorescence 2020 ·Methods and Applications in Fluorescence ·Jens Sobek, Marco F. Schmidt, Jonas Grossmann, Hubert Rehrauer, (unknown), Ralph Schlapbach	4
5	Improving FoRe: A New Inlet Design for Filtering Samples through Individual Microarray Spots 2017 ·ACS Sensors ·(unknown), (unknown), Marco F. Schmidt, János Vörös	5
6	Antagonists of the miRNA-Argonaute 2 Protein Complex: Anti-miR-AGOs 2016 ·Methods in molecular biology ·Marco F. Schmidt, Oliver Korb, Chris Abell	1
7	Drug Target miRNA 2016 ·Methods in molecular biology ·Marco F. Schmidt	4
8	Drug target miRNAs: chances and challenges 2014 ·Trends in biotechnology ·Marco F. Schmidt	111
9	Design and Structural Analysis of Aromatic Inhibitors of Type II Dehydroquinase from Mycobacterium tuberculosis 2014 ·ChemMedChem ·Nigel Howard, M.V.B. Dias, Fabienne Peyrot, Liuhong Chen, Marco F. Schmidt, Tom L. Blundell, Chris Abell	7
10	Discovery of Schaeffer’s Acid Analogues as Lead Structures of Mycobacterium tuberculosis Type II Dehydroquinase Using a Rational Drug Design Approach 2012 ·ChemMedChem ·Marco F. Schmidt, Oliver Korb, Nigel Howard, M.V.B. Dias, Tom L. Blundell, Chris Abell	11
11	Dynamic Substrate Enhancement for the Identification of Specific, Second‐Site‐Binding Fragments Targeting a Set of Protein Tyrosine Phosphatases 2011 ·ChemBioChem ·Marco F. Schmidt, Matthew R. Groves, Jörg Rademann	23
12	Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease 2011 ·Antiviral Research ·Li Zhu, (unknown), Marco F. Schmidt, Samer Al‐Gharabli, Jörg Rademann, Rolf Hilgenfeld	96
13	Design, Synthesis, and Qualitative Structure–Activity Evaluations of Novel β-Secretase Inhibitors as Potential Alzheimer’s Drug Leads 2011 ·Journal of Medicinal Chemistry ·Taleb H. Al‐Tel, Mohammad H. Semreen, Raed A. Al‐Qawasmeh, Marco F. Schmidt, (unknown), Mustafa T. Ardah, Rania Faouzi Zaarour, Shashidhar N. Rao, Omar M. A. El‐Agnaf	40
14	Dynamic template-assisted strategies in fragment-based drug discovery 2009 ·Trends in biotechnology ·Marco F. Schmidt, Jörg Rademann	42
15	Selective Identification of Cooperatively Binding Fragments in a High‐Throughput Ligation Assay Enables Development of a Picomolar Caspase‐3 Inhibitor 2009 ·Angewandte Chemie International Edition ·Marco F. Schmidt, (unknown), Sandro Keller, Jörg Rademann	43
16	Rational Design and Synthesis of Potent Dibenzazepine Motifs as β-Secretase Inhibitors 2009 ·Journal of Medicinal Chemistry ·Taleb H. Al‐Tel, Raed A. Al‐Qawasmeh, Marco F. Schmidt, Amal Al‐Aboudi, Shashidhar N. Rao, Salim S. Sabri, Wolfgang Voelter	31
17	Selektive Detektion kooperativ bindender Fragmente in einem Hochdurchsatz‐Ligationsassay zur Entwicklung eines pikomolaren Caspase‐3‐Inhibitors 2009 ·Angewandte Chemie ·Marco F. Schmidt, (unknown), Sandro Keller, Jörg Rademann	19
18	Sensitized Detection of Inhibitory Fragments and Iterative Development of Non‐Peptidic Protease Inhibitors by Dynamic Ligation Screening 2008 ·Angewandte Chemie International Edition ·Marco F. Schmidt, Albert Isidro‐Llobet, Michael Lisurek, (unknown), Jinzhi Tan, Rolf Hilgenfeld, Jörg Rademann	59
19	Sensibilisierte Detektion inhibitorischer Fragmente und iterative Entwicklung nicht‐peptidischer Proteaseinhibitoren durch dynamisches Ligationsscreening 2008 ·Angewandte Chemie ·Marco F. Schmidt, Albert Isidro‐Llobet, Michael Lisurek, (unknown), Jinzhi Tan, Rolf Hilgenfeld, Jörg Rademann	29
20	An Efficient Method for the Synthesis of Peptide Aldehyde Libraries Employed in the Discovery of Reversible SARS Coronavirus Main Protease (SARS‐CoV M^pro) Inhibitors 2006 ·ChemBioChem ·Samer Al‐Gharabli, Syed Tasadaque Ali Shah, Steffen Weik, Marco F. Schmidt, J.R. Mesters, Daniel Kühn, G. Klebe, Rolf Hilgenfeld, Jörg Rademann	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact